Daratumumab (anti-CD38)

Ask the supplier | View on supplier's website

Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa.

Supplier	Selleck Chemicals
Product #	A2027
Sku #	A2027-1mg
Pricing	1mg, $237.00

Feedback